批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2018/08/06 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/03/09 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2011/10/21 |
SUPPL-14(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2004/03/03 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1987/01/02 |
SUPPL-11(补充) |
Approval |
Labeling |
|
|
|
1984/07/31 |
SUPPL-7(补充) |
Approval |
Labeling |
|
|
|
1983/08/15 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1982/07/12 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1979/11/21 |
SUPPL-4(补充) |
Approval |
Efficacy |
|
|
|
1979/01/16 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1978/07/20 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1976/05/17 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:GALLIUM CITRATE GA-67 剂型/给药途径:INJECTABLE;INJECTION 规格:2mCi/ML 治疗等效代码:BS
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
017478 |
001 |
NDA |
GALLIUM CITRATE GA 67 |
GALLIUM CITRATE GA-67 |
INJECTABLE;INJECTION |
2mCi/ML |
Discontinued |
No |
No |
BS |
Approved Prior to Jan 1, 1982
|
LANTHEUS MEDCL |
018058 |
001 |
NDA |
GALLIUM CITRATE GA 67 |
GALLIUM CITRATE GA-67 |
INJECTABLE;INJECTION |
2mCi/ML |
Prescription |
No |
No |
BS |
Approved Prior to Jan 1, 1982
|
CURIUM |